Cargando…
Factors Associated with Failure of Intermittent Nebulization with Short-Acting Beta-Agonists in Children with Severe Asthma Exacerbation
PURPOSE: Intermittent nebulization of short-acting beta-agonists (SABA) is the initial treatment of choice for children with asthma exacerbation. However, children with severe asthma exacerbation (SAE) may not show an adequate response and need aggressive stepwise therapy. We aimed to explore factor...
Autores principales: | Kulalert, Prapasri, Phinyo, Phichayut, Patumanond, Jayanton, Smathakanee, Chutima, Chuenjit, Wantida, Nanthapisal, Sira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457559/ https://www.ncbi.nlm.nih.gov/pubmed/32904643 http://dx.doi.org/10.2147/JAA.S258549 |
Ejemplares similares
-
Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching analysis
por: Kulalert, Prapasri, et al.
Publicado: (2020) -
Development Of A Clinical Predictive Score For Allergic Reactions To COVID-19 Vaccine (AZD1222)
por: Thanborisutkul, Karnsinee, et al.
Publicado: (2023) -
Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
por: Kulalert, Prapasri, et al.
Publicado: (2022) -
Prognostic indicators for in-hospital mortality in COPD with acute exacerbation in Thailand: a retrospective cohort study
por: Morasert, Thotsaporn, et al.
Publicado: (2020) -
The MAGENTA model for individual prediction of in-hospital mortality in chronic obstructive pulmonary disease with acute exacerbation in resource-limited countries: A development study
por: Mekanimitdee, Prachya, et al.
Publicado: (2021)